Detalles de la búsqueda
1.
A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis.
N Engl J Med
; 390(9): 783-794, 2024 Feb 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38381664
2.
Long-term persistence of HCV resistance-associated substitutions after DAA treatment failure.
J Hepatol
; 78(1): 57-66, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36031158
3.
A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B.
J Hepatol
; 78(5): 926-936, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37062574
4.
Real-world experience for the outcomes and costs of treating hepatitis C patients: Results from the German Hepatitis C-Registry (DHC-R).
Z Gastroenterol
; 61(5): 489-503, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35839795
5.
Clinical characteristics of patients with non-alcoholic fatty liver disease (NAFLD) in Germany - First data from the German NAFLD-Registry.
Z Gastroenterol
; 61(1): 60-70, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36623544
6.
Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1-3 Infections.
Clin Gastroenterol Hepatol
; 19(1): 195-198.e2, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31706062
7.
Ledipasvir/Sofosbuvir for 8, 12, or 24 Weeks in Hepatitis C Patients Undergoing Dialysis for End-Stage Renal Disease.
Am J Gastroenterol
; 116(9): 1924-1928, 2021 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34465694
8.
The changing characteristics of patients infected with chronic hepatitis C virus from 2014 to 2019: Real-world data from the German Hepatitis C-Registry (DHC-R).
J Viral Hepat
; 28(10): 1474-1483, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34339561
9.
[Evolution of hepatitis C virus genotype 1a vs. 1b distribution in Germany between 2004 and 2018 - An analysis of 17093 patients from different real world registries]. / Veränderungen der Hepatitis-C-Virus-Genotyp-1a/1b-Verteilung zwischen 2004 und 2018 in Deutschland eine Analyse von 17093 Patienten aus verschiedenen Real-World-Registern.
Z Gastroenterol
; 59(3): 241-249, 2021 Mar.
Artículo
en Alemán
| MEDLINE | ID: mdl-33684956
10.
Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection.
N Engl J Med
; 376(22): 2134-2146, 2017 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28564569
11.
Resistance-associated substitutions in patients with chronic hepatitis C virus genotype 4 infection.
J Viral Hepat
; 27(10): 974-986, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32396998
12.
JNJ-4178 (AL-335, Odalasvir, and Simeprevir) for 6 or 8 Weeks in Hepatitis C Virus-Infected Patients Without Cirrhosis: OMEGA-1.
Hepatology
; 69(6): 2349-2363, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30693573
13.
Baseline risk factors determine lack of biochemical response after SVR in chronic hepatitis C patients treated with DAAs.
Liver Int
; 40(3): 539-548, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31241820
14.
Treatment outcomes in hepatitis C virus genotype 1a infected patients with and without baseline NS5A resistance-associated substitutions.
Liver Int
; 2020 Jul 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32640072
15.
Management of hepatic encephalopathy in Germany: a survey among physicians.
Z Gastroenterol
; 58(1): 49-56, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31931540
16.
Treatment-failure to direct antiviral HCV regimens in real world: frequency, patient characteristics and rescue therapy - data from the German hepatitis C registry (DHC-R).
Z Gastroenterol
; 58(4): 341-351, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32040979
17.
Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals.
Gastroenterology
; 154(4): 976-988.e4, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29146520
18.
Real-world safety and effectiveness of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C virus genotype 1- and 4-infected patients with diverse comorbidities and comedications: A pooled analysis of post-marketing observational studies from 13 countries.
J Viral Hepat
; 26(6): 685-696, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30739368
19.
Estimation of liver fibrosis by noncommercial serum markers in comparison with transient elastography in patients with chronic hepatitis C virus infection receiving direct-acting antiviral treatment.
J Viral Hepat
; 26(2): 224-230, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30315694
20.
Ten-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infection.
Liver Int
; 39(10): 1868-1875, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31136052